Jaguar Health seeks shareholder approval to expand stock incentive plan to 378,859 shares
JAGX•Jaguar Health is seeking shareholder approval on November 6, 2026, to increase authorized shares under its 2014 Stock Incentive Plan to 378,859. If approved, 2,273,154 shares would be available; if rejected, 4,260 would remain available.
1. Plan amendment proposal
Jaguar Health is seeking shareholder approval to amend its 2014 Stock Incentive Plan at a November 6, 2026, meeting. A sixfold reserve adjustment would take effect immediately after the meeting to reflect the Series R Preferred Stock Dividend. If shareholders approve the amendment, available shares would total 2,273,154, about 14% of fully diluted common shares outstanding as of September 30, 2026; if they reject it, 4,260 shares would remain available. The adjusted incentive stock option limit would be 163,998 shares under either outcome, and the board’s voting recommendations remain unchanged.
